On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

In patients with inflammatory bowel diseases (IBD) undergoing biologic therapy, biomarkers of treatment response are still scarce. This study aimed to evaluate whether serum zonulin, a biomarker of intestinal permeability; soluble CD163 (sCD163), a macrophage activation marker; and a panel of serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Caviglia, Gian Paolo, Rosso, Chiara, Stalla, Francesco, Rizzo, Martina, Massano, Alessandro, Abate, Maria Lorena, Olivero, Antonella, Armandi, Angelo, Vanni, Ester, Younes, Ramy, Fagoonee, Sharmila, Pellicano, Rinaldo, Astegiano, Marco, Saracco, Giorgio Maria, Bugianesi, Elisabetta, Ribaldone, Davide Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141255/
https://www.ncbi.nlm.nih.gov/pubmed/32183476
http://dx.doi.org/10.3390/jcm9030800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141255/
https://www.ncbi.nlm.nih.gov/pubmed/32183476
http://dx.doi.org/10.3390/jcm9030800

Ejemplares similares